Skip to main content
ALNYLAM PHARMACEUTICALS, INC. logo

ALNYLAM PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · ALNY ISIN · US72703U1025 LEI · 529900S3ZI14OWRJII50 US Manufacturing
Filings indexed 1,231 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country US United States of America
Listing US ALNY

About ALNYLAM PHARMACEUTICALS, INC.

https://www.alnylam.com/

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company that pioneers and leads the development of RNA interference (RNAi) therapeutics. The company is dedicated to translating the science of RNAi into a new class of innovative medicines. Its core activities encompass the research, development, manufacturing, and commercialization of therapies that utilize RNAi's natural biological process of gene silencing to target the genetic drivers of disease. This approach offers a novel mechanism for treating a range of debilitating conditions, with a focus on delivering transformational medicines to patients.

Recent filings

Filing Released Lang Actions
8-K - ALNYLAM PHARMACEUTICALS, INC. (0001178670) (Filer)
Regulatory Filings
2026-04-30 English
ARS - ALNYLAM PHARMACEUTICALS, INC. (0001178670) (Filer)
Annual Report
2026-04-06 English
DEF 14A - ALNYLAM PHARMACEUTICALS, INC. (0001178670) (Filer)
Proxy Solicitation & Information Statement
2026-04-06 English
SCHEDULE 13G/A - ALNYLAM PHARMACEUTICALS, INC. (0001178670) (Subject)
Major Shareholding Notification
2026-03-26 English
4 - ALNYLAM PHARMACEUTICALS, INC. (0001178670) (Filer)
Director's Dealing
2026-03-02 English
4 - ALNYLAM PHARMACEUTICALS, INC. (0001178670) (Filer)
Director's Dealing
2026-03-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.